Please wait while the formulary information is being retrieved.
CABTREO (adapalene/benzoyl peroxide/clindamycin phosphate)
- acne
0.15 %-3.1 %-1.2 % topical gel
- Apply a thin layer to the affected area(s) after washing by topical route once daily
Default screening record
- Apply a thin layer to the affected area(s) after washing by topical route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- Crohn's disease
- Pregnancy
- Ulcerative colitis
Contraindicated
- Clostridioides difficile infection
- Exfoliative dermatitis
- Skin photosensitivity
Severe
Moderate
- Atopic dermatitis
CABTREO (adapalene/benzoyl peroxide/clindamycin phosphate)
- acne
- Erythema
- Pruritus of skin
- Abnormal desquamation
- Dry skin
- Erythema
- Pruritus of skin
- Skin irritation
- Skin scaling
- Stinging of skin
More Frequent
Severe
Less Severe
- Skin irritation
- Abnormal desquamation
- Atopic dermatitis
- Dry skin
- Erythema
- Headache disorder
- Oily skin
- Sensation of warmth
- Skin irritation
- Stinging of skin
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Angioedema
- Bloody diarrhea
- Clostridioides difficile infection
- Dermatitis due to topical drug
- Dyspnea
- Eczema
- Eyelid edema
- Facial edema
- Hypersensitivity drug reaction
- Periorbital edema
- Pharyngeal edema
- Pruritus of skin
- Skin rash
- Syncope
- Throat constriction
- Urticaria
Less Severe
- Acute abdominal pain
- Conjunctivitis
- Contact dermatitis
- Diarrhea
- Dyschromia
- Gram-negative folliculitis
- Lip swelling
- Ocular pain
- Skin inflammation
- Skin photosensitivity
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Adapalene (0.1%)
Safety and efficacy not established age < 9 years.
Safety and efficacy not established age < 12 years.
- 1 Day – 9 Years
- Safety and efficacy not established age < 9 years.
- 1 Day – 12 Years
- Safety and efficacy not established age < 9 years.
Clindamycin (Topical)
Safety and efficacy not established age < 9 years.
Safety and efficacy not established age < 12 years.
- 1 Day – 9 Years
- Safety and efficacy not established age < 12 years.
- 1 Day – 12 Years
- Safety and efficacy not established age < 12 years.
Adapalene
- Severity Level:
1
- Additional Notes: Retinoid-like activity; theoretical concern of dev tox
Benzoyl Peroxide
- Severity Level:
2
- Additional Notes: Single ingredient products are topical and otc
Clindamycin (top, Vag)
- Severity Level:
2
- Additional Notes: Insuff human and animal data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Adapalene
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
Benzoyl Peroxide
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
Clindamycin (top, Vag)
Avoiding nipple area application will reduce infants risk for diarrhea
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Avoiding nipple area application will reduce infants risk for diarrhea |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Acne vulgaris | |
| L70.0 | Acne vulgaris |
| 0-9 | A-Z |
|---|---|
| L70.0 | Acne vulgaris |
Formulary Reference Tool